COMPANY PROFILE

BCIFlex

Explore full profile

AI-powered brain-computer interfaces for medical research applications

Guangzhou, ChinaFounded 2022Health Tech & Medtech

Valuation $250–500M Last recorded · 2025

Total funding $10–50M Disclosed equity funding

Unlock exact values

About BCIFlex

BCIFlex is a life sciences company, founded in 2022 and headquartered in Beijing, China, that specializes in the development of brain-computer interfaces for the medical industry. The firm develops artificial intelligence application system integration services aimed at enhancing the efficiency of medical research and experimental development for its users. Its products include implantable stretchable flexible neural electrodes.

The company's intellectual property includes patents for a flexible neural electrode composite structure and its manufacturing and implantation methods, which are designed to improve operational flexibility and post-implantation stability. In 2025, BCIFlex secured over RMB 300 million (approximately USD 42 million) in a Series A funding round. The round was co-led by a fund managed by Legend Capital Management and IDG Capital, with participation from investors such as Yuanbio Venture Capital, China Life Capital, Lenovo Capital, Meituan's DragonBall Capital, and Baidu Venture.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2022
Headquarters: Guangzhou, China
Open positions: None listed
Dealroom signal: 18.7/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, medical implants, Neurology, Brain Computer Interfaces, DT and LS, science-based
Technology: Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Aug 2025	$42M	$168M	China Life Investment Management · Legend Capital · YuanBio Venture Capital	↗

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
NENeuroXessFlexible brain-computer interface for neurological restoration	Minhang District, China	Operational	5	$13M	$53M
NBNeurosoft BioelectronicsImproving the care of patients who suffer from neurological disorders by developing soft implantable electrodes to interface with the nervous system	Geneva, Switzerland	Operational
NENeuroPaceDeveloping and marketing implantable devices for the treatment of neurological disorders	Mountain View, United States	Operational
MLMerge LabsDeveloping non-invasive brain-computer interface technology to enable direct communication between the human brain and computers	Palo Alto, United States	Operational
NTNeural Dynamics TechnologiesDesigning and building innovative neural interfaces	Boston, United States	Operational
NENewronikaRestores brain and body functions with neural devices based on biosignal decoding	Cologno Monzese, Italy	Operational
COCorTecDeveloping the world’s most efficient implants serving as a direct interface between brain and technology	Freiburg, Germany	Operational
JIJiMED a medical device venture from Osaka University that is responsible for the social implementation of the implantable BCI (Brain Computer Interface)	Suita-Shi, Japan	Operational